Profile
Pacific 8 Ventures is a venture capital firm focused on building technology companies that transform healthcare. Based in the US, the firm was founded to leverage disruptive technology platforms making advancements in therapeutics, diagnostics, and broader health services. The team includes professionals with clinical, healthcare technology, and investment experience, including Ser-Chen, MD, faculty at Tzu-Chi University; Jack, with significant sales and alliance experience in the healthcare technology field; and Chris, with over 15 years of experience in venture capital and technology transformations in the US and Asia.
The firm primarily invests in the seed stage and prefers to be the first institutional investor for companies at the nexus of healthcare and disruptive technology platforms. Pacific 8 Ventures mainly targets the US market, which it identifies as being at the forefront of disruptive innovations. The firm aims to find opportunities within therapeutics, diagnostics, and health tech services to drive innovation.
Notable portfolio companies include Hill Research - advanced diagnostics, Elsa Fertility - fertility solutions, Certainly Health - health application platform, Empirical Health - therapeutic platforms, and Matrisome Bio - biological research. Others include Mammoth Biosciences - gene editing technologies and BillionToOne - molecular diagnostics. These companies represent Pacific 8 Ventures' focus on health tech innovation and transformative healthcare solutions.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.